498 related articles for article (PubMed ID: 15482952)
1. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozyme II and mitochondrial isozyme V with a series of benzene sulfonamide derivatives.
Innocenti A; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Nov; 14(22):5703-7. PubMed ID: 15482952
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase inhibitors. Inhibition of mitochondrial isozyme V with aromatic and heterocyclic sulfonamides.
Vullo D; Franchi M; Gallori E; Antel J; Scozzafava A; Supuran CT
J Med Chem; 2004 Feb; 47(5):1272-9. PubMed ID: 14971907
[TBL] [Abstract][Full Text] [Related]
3. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
[TBL] [Abstract][Full Text] [Related]
4. Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Vullo D; Innocenti A; Scozzafava A; Mastrolorenzo A; Supuran CT
J Med Chem; 2005 Dec; 48(24):7860-6. PubMed ID: 16302824
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide.
Cecchi A; Winum JY; Innocenti A; Vullo D; Montero JL; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Dec; 14(23):5775-80. PubMed ID: 15501039
[TBL] [Abstract][Full Text] [Related]
6. Carbonic anhydrase inhibitors. Aromatic/heterocyclic sulfonamides incorporating phenacetyl, pyridylacetyl and thienylacetyl tails act as potent inhibitors of human mitochondrial isoforms VA and VB.
Güzel O; Innocenti A; Scozzafava A; Salman A; Supuran CT
Bioorg Med Chem; 2009 Jul; 17(14):4894-9. PubMed ID: 19539481
[TBL] [Abstract][Full Text] [Related]
7. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
[TBL] [Abstract][Full Text] [Related]
8. Carbonic anhydrase inhibitors: 2-substituted-1,3,4-thiadiazole-5-sulfamides act as powerful and selective inhibitors of the mitochondrial isozymes VA and VB over the cytosolic and membrane-associated carbonic anhydrases I, II and IV.
Smaine FZ; Pacchiano F; Rami M; Barragan-Montero V; Vullo D; Scozzafava A; Winum JY; Supuran CT
Bioorg Med Chem Lett; 2008 Dec; 18(24):6332-5. PubMed ID: 18990571
[TBL] [Abstract][Full Text] [Related]
9. Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides.
Innocenti A; Firnges MA; Antel J; Wurl M; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):1149-54. PubMed ID: 15686931
[TBL] [Abstract][Full Text] [Related]
10. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs?
Vullo D; Innocenti A; Nishimori I; Pastorek J; Scozzafava A; Pastoreková S; Supuran CT
Bioorg Med Chem Lett; 2005 Feb; 15(4):963-9. PubMed ID: 15686894
[TBL] [Abstract][Full Text] [Related]
11. Carbonic anhydrase inhibitors: inhibition of cytosolic/tumor-associated isoforms I, II, and IX with iminodiacetic carboxylates/hydroxamates also incorporating benzenesulfonamide moieties.
Santos MA; Marques S; Vullo D; Innocenti A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2007 Mar; 17(6):1538-43. PubMed ID: 17251018
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors.
Nishimori I; Minakuchi T; Onishi S; Vullo D; Scozzafava A; Supuran CT
J Med Chem; 2007 Jan; 50(2):381-8. PubMed ID: 17228881
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase inhibitors: inhibition of the human isozymes I, II, VA, and IX with a library of substituted difluoromethanesulfonamides.
Cecchi A; Taylor SD; Liu Y; Hill B; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2005 Dec; 15(23):5192-6. PubMed ID: 16203142
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and docking studies of new 1,3,4-thiadiazole-2-thione derivatives with carbonic anhydrase inhibitory activity.
Abdel-Hamid MK; Abdel-Hafez AA; El-Koussi NA; Mahfouz NM; Innocenti A; Supuran CT
Bioorg Med Chem; 2007 Nov; 15(22):6975-84. PubMed ID: 17822907
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
[TBL] [Abstract][Full Text] [Related]
16. Carbonic anhydrase inhibitors. Identification of selective inhibitors of the human mitochondrial isozymes VA and VB over the cytosolic isozymes I and II from a natural product-based phenolic library.
Davis RA; Innocenti A; Poulsen SA; Supuran CT
Bioorg Med Chem; 2010 Jan; 18(1):14-8. PubMed ID: 19962903
[TBL] [Abstract][Full Text] [Related]
17. Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides.
Wilkinson BL; Bornaghi LF; Houston TA; Innocenti A; Vullo D; Supuran CT; Poulsen SA
J Med Chem; 2007 Apr; 50(7):1651-7. PubMed ID: 17343373
[TBL] [Abstract][Full Text] [Related]
18. Carbonic anhydrase inhibitors. Inhibition of cytosolic isozyme XIII with aromatic and heterocyclic sulfonamides: a novel target for the drug design.
Lehtonen JM; Parkkila S; Vullo D; Casini A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2004 Jul; 14(14):3757-62. PubMed ID: 15203157
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase inhibitors. Synthesis, molecular structures, and inhibition of the human cytosolic isozymes I and II and transmembrane isozymes IX, XII (cancer-associated) and XIV with novel 3-pyridinesulfonamide derivatives.
Brzozowski Z; Sławiński J; Gdaniec M; Innocenti A; Supuran CT
Eur J Med Chem; 2011 Sep; 46(9):4403-10. PubMed ID: 21820216
[TBL] [Abstract][Full Text] [Related]
20. In vitro inhibition of salicylic acid derivatives on human cytosolic carbonic anhydrase isozymes I and II.
Bayram E; Senturk M; Kufrevioglu OI; Supuran CT
Bioorg Med Chem; 2008 Oct; 16(20):9101-5. PubMed ID: 18819808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
